Back
Corcept Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
67
CORT
Corcept Therapeutics
Last Price:
47.60
Seasonality Move:
5.4%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- The current trend is moderately bullish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.37 | Sell |
| 20-day SMA: | 46.83 | Buy |
| 50-day SMA: | 41.33 | Buy |
| 200-day SMA: | 30.89 | Buy |
| 8-day EMA: | 47.85 | Buy |
| 20-day EMA: | 46.45 | Buy |
| 50-day EMA: | 42.58 | Buy |
| 200-day EMA: | 33.94 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.88 | Buy |
| Relative Strength Index (14 RSI): | 63.92 | Buy |
| Chaikin Money Flow: | 48996 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.43 - 48.09) | Buy |
| Bollinger Bands (100): | (31.13 - 43.07) | Buy |
Corcept Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 48.22 while CORT 8-day simple moving average is 48.37, which is a Sell signal.
- The stock price of CORT is 48.22 while Corcept Therapeutics 20-day SMA is 46.83, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 41.33 while CORT share price is 48.22, making it a Buy technically.
- CORT stock price is 48.22 and Corcept Therapeutics 200-day simple moving average is 30.89, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $48.22. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
5.04B
Price in USD:
48.22
Share Volume:
604.29K
Corcept Therapeutics 52-Week Range
52-Week High:
50.07
52-Week Low:
20.84
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 48.22 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 48.22 while CORT 8-day exponential moving average is 47.85, which is a Buy signal.
- The stock price of CORT is 48.22 while Corcept Therapeutics 20-day EMA is 46.45, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 42.58 while CORT share price is 48.22, making it a Buy technically.
- CORT stock price is 48.22 and Corcept Therapeutics 200-day simple moving average is 33.94, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.76 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is 1.88, suggesting Corcept Therapeutics is a Buy
- Corcept Therapeutics Relative Strength Index (RSI) is 63.92, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (44.43 - 48.09), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (31.13 - 43.07), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.